drugset / Trial / NCT02031055
Study of the Mass Balance of Oral FTD and TPI as Components of TAS-102 in Patients With Advanced Solid Tumors
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate, in patients with advanced solid tumors, the mass balance of FTD and TPI after a single dose of TAS-102 with a light tracer dose of \[14C\]FTD or \[14C\]TPI.
Timeline
- Start
- 2014-02
- Primary completion
- 2014-11
- Completion
- 2015-06-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | FTD | Unknown | 1.2 ug | Oral |
| Subject | TPI | Unknown | 5.6 ug | Oral |